Monday, October 14, 2019
Home WuXi News Volume #001 - June 2019

Volume #001 - June 2019

The Game-Changing Potential of Targeting RNA with Small Molecules: More Than Turning the Undruggable...

By Rich Soll, Senior Advisor, Strategic Initiatives, WuXi AppTec (@richsollwx) Once considered impossible, targeting RNA with small molecules has the potential to be a game-changer. It’s convincing enough to industry veteran Michael...

WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development

Shanghai, China & San Diego, California May 6, 2019 - WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced that it has acquired...

SUBSCRIBE TO OUR NEWSLETTER

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast...

SHANGHAI, CHINA; CAMBRIDGE, MASSACHUSETTS, USA; SANKT AUGUSTIN, GERMANY Oct 10, 2019 - WuXi AppTec Research Service Division and BioSolveIT today launched a new virtual...